Outcomes by age with neoadjuvant atezolizumab treatment for resectable non-small cell lung cancer in the phase 2 LCMC3 study Meeting Abstract


Authors: Presley, C.; Owen, D. H.; Nicholas, A.; Hilz, S.; Oezkan, F.; Chaft, J. E.; Toloza, E. M.; Haura, E. B.; Patterson, A.; Waqar, S. N.; Bunn, P.; Johnson, B. E.; Kris, M. G.; Lee, J. M.; Kwiatkowski, D. J.; Wistuba, I. I.; Schulze, K.; Johnson, A.; Rusch, V. W.; Carbone, D. P.
Abstract Title: Outcomes by age with neoadjuvant atezolizumab treatment for resectable non-small cell lung cancer in the phase 2 LCMC3 study
Meeting Title: 2023 World Conference on Lung Cancer (IASLC-WCLC)
Journal Title: Journal of Thoracic Oncology
Volume: 18
Issue: 11 Suppl.
Meeting Dates: 2023 Sep 9-11
Meeting Location: Singapore
ISSN: 1556-0864
Publisher: Elsevier Inc.  
Date Published: 2023-11-01
Start Page: S275
End Page: S276
Language: English
DOI: 10.1016/j.jtho.2023.09.470
PROVIDER: EBSCOhost
PROVIDER: cinahl
DOI/URL:
Notes: Meeting Abstract: P1.25-16 -- Source: Cinahl
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Valerie W Rusch
    865 Rusch
  2. Jamie Erin Chaft
    289 Chaft
  3. Mark Kris
    869 Kris